[The clinical course of nodular type hepatocellular carcinomas after transcatheter arterial embolization (TAE) therapy].
TAEs were performed for 14 cases of nodular type hepatocellular carcinomas. The tumor size in 10 of the 14 cases was less than 5.0 cm in diameter. After 2 to 3 TAEs for each of the cases, tumor regression was noted in 11 cases and a decrease in the serum AFP in every case. The 1-year survival rate (1 YSR) was 79%, the 2YSR was 42%, and 3YSR was 10%, Re-growth of the tumors was observed in 45% of the cases 1-year after, and in all cases 2-year after. In cases which had multiple nodules or an incomplete capsule or a poor accumulation of Lipiodol, re-growth occurred even earlier.
Suyama
Y
Y
3rd Dept. of Int. Med., Kyoto First Red Cross Hospital.
Kitagawa
Y
Y
Horishi
M
M
Shizumi
Y
Y
Yashige
H
H
Fujii
H
H
Miyoshi
M
M
D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D006528:Carcinoma, Hepatocellular / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D004317:Doxorubicin / Q000008:administration & dosage; D004621:Embolization, Therapeutic / Q000379:methods; D005260:Female; D006499:Hepatic Artery; D006801:Humans; D007459:Iodized Oil / Q000627:therapeutic use; D008113:Liver Neoplasms / Q000401:mortality / Q000473:pathology / Q000628:therapy*; D016685:Mitomycin; D008937:Mitomycins / Q000008:administration & dosage; D009364:Neoplasm Recurrence, Local; D011379:Prognosis; D012074:Remission Induction; D000509:alpha-Fetoproteins / Q000032:analysis
D008937:Mitomycins; D000509:alpha-Fetoproteins; D016685:Mitomycin; D007459:Iodized Oil; D004317:Doxorubicin